229 related articles for article (PubMed ID: 8610164)
1. Major histocompatibility complex class I molecule serves as a ligand for presentation of the superantigen staphylococcal enterotoxin B to T cells.
Häffner AC; Zepter K; Elmets CA
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3037-42. PubMed ID: 8610164
[TBL] [Abstract][Full Text] [Related]
2. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
Lamphear JG; Stevens KR; Rich RR
J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
[TBL] [Abstract][Full Text] [Related]
3. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
Brogan PA; Shah V; Klein N; Dillon MJ
Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies defining functional sites on the toxin superantigen staphylococcal enterotoxin B.
Hamad AR; Herman A; Marrack P; Kappler JW
J Exp Med; 1994 Aug; 180(2):615-21. PubMed ID: 7519243
[TBL] [Abstract][Full Text] [Related]
5. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
Ijichi S; Yamano Y; Osame M; Hall WW
Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
[TBL] [Abstract][Full Text] [Related]
6. Variable influence of MHC polymorphism on the recognition of bacterial superantigens by T cells.
Wen R; Blackman MA; Woodland DL
J Immunol; 1995 Aug; 155(4):1884-92. PubMed ID: 7636239
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.
von Bonin A; Ehrlich S; Malcherek G; Fleischer B
Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089
[TBL] [Abstract][Full Text] [Related]
8. Synovial cells are potent antigen-presenting cells for superantigen, staphylococcal enterotoxin B (SEB).
Origuchi T; Eguchi K; Kawabe Y; Mizokami A; Ida H; Nagataki S
Clin Exp Immunol; 1995 Mar; 99(3):345-51. PubMed ID: 7882555
[TBL] [Abstract][Full Text] [Related]
9. Human natural killer (NK) cells present staphylococcal enterotoxin B (SEB) to T lymphocytes.
D'Orazio JA; Stein-Streilein J
Clin Exp Immunol; 1996 May; 104(2):366-73. PubMed ID: 8625534
[TBL] [Abstract][Full Text] [Related]
10. T-cell stimulation and cytokine release induced by staphylococcal enterotoxin A (SEA) and the SEAD227A mutant.
Holzer U; Orlikowsky T; Zehrer C; Bethge W; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
Immunology; 1997 Jan; 90(1):74-80. PubMed ID: 9038715
[TBL] [Abstract][Full Text] [Related]
11. Superantigen-staphylococcal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells.
Holzer U; Bethge W; Krull F; Ihle J; Handgretinger R; Reisfeld RA; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
Cancer Immunol Immunother; 1995 Aug; 41(2):129-36. PubMed ID: 7656271
[TBL] [Abstract][Full Text] [Related]
12. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
Surman S; Deckhut AM; Blackman MA; Woodland DL
J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors.
Papageorgiou AC; Tranter HS; Acharya KR
J Mol Biol; 1998 Mar; 277(1):61-79. PubMed ID: 9514739
[TBL] [Abstract][Full Text] [Related]
14. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.
Ihle J; Holzer U; Krull F; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
Cancer Res; 1995 Feb; 55(3):623-8. PubMed ID: 7530598
[TBL] [Abstract][Full Text] [Related]
15. Cell adhesion molecules are co-receptors for staphylococcal enterotoxin B-induced T-cell activation and cytokine production.
Krakauer T
Immunol Lett; 1994 Feb; 39(2):121-5. PubMed ID: 8013959
[TBL] [Abstract][Full Text] [Related]
16. Interferon gamma-treated keratinocytes activate T cells in the presence of superantigens: involvement of major histocompatibility complex class II molecules.
Strange P; Skov L; Baadsgaard O
J Invest Dermatol; 1994 Feb; 102(2):150-4. PubMed ID: 7906285
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigen-class II-negative long-term cultured human T-cell leukemia virus type-I-infected T-cell lines with progressed cytological properties significantly induce superantigen-dependent normal T-cell proliferation.
Nagasaki M; Zhang J; Morikawa S; Harada T; Nabika T; Tanaka Y
Pathol Int; 2005 May; 55(5):264-72. PubMed ID: 15871724
[TBL] [Abstract][Full Text] [Related]
18. Synovial fibroblasts as accessory cells for staphylococcal enterotoxin-mediated T-cell activation.
Kraft M; Filsinger S; Krämer KL; Kabelitz D; Hänsch GM; Schoels M
Immunology; 1995 Jul; 85(3):461-6. PubMed ID: 7558136
[TBL] [Abstract][Full Text] [Related]
19. Effects of antigen presentation on superantigen-induced apoptosis mediated by Fas/Fas ligand interactions in human T cells.
Boshell M; McLeod J; Walker L; Hall N; Patel Y; Sansom D
Immunology; 1996 Apr; 87(4):586-92. PubMed ID: 8675213
[TBL] [Abstract][Full Text] [Related]
20. Activation of T cells by superantigen in class II-negative mice.
Avery AC; Markowitz JS; Grusby MJ; Glimcher LH; Cantor H
J Immunol; 1994 Dec; 153(11):4853-61. PubMed ID: 7963549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]